Kit for testing partial thromboplastin time of medical instrument and application
By using high-density polyethylene particles, non-silylated glass particles, freeze-dried rabbit cerephospholipids and ion-free ultrapure water in the kit, the leaching and preparation methods are improved, and partial coagulation of medical devices in the prior art is solved. The hemolysis and dissolution problems of active enzyme time achieve more stable and accurate test results.
Patent Information
- Application Number
- CN202411547836.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-11-01
- Publication Date
- 2024-11-29
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
In the prior art, when detecting the thromboplastin time of part of medical devices, there are problems such as platelet activation coagulation reaction, hemolysis, unstable plasma samples, and insufficient dissolution of rabbit cerephospholipids, which affect the accuracy and stability of the detection results. .
Provide a kit for testing the thromboplastin time of medical devices, including high-density polyethylene particles, non-silylated glass particles, lyophilized rabbit cerephospholipids and ion-free ultrapure water, through improved leaching and formulation methods, Ensure the stability of plasma samples and complete dissolution of rabbit cerephospholipids, reduce hemolysis, and use pure water instead of normal saline to improve dissolution effect.
It significantly improves the stability and accuracy of the test results, reduces hemolysis, ensures the reliability of the duplicate results, meets the standard requirements, and improves the reliability and consistency of the test data.
Smart Images

Figure SMS_1 
Figure SMS_3 
Figure SMS_5
Abstract
Description
Technical Field
[0001] The invention relates to a kit for testing the partial thromboplastin time of a medical device and application thereof, belonging to the technical field of medicine. Background Art
[0002] The partial thromboplastin time (PTT) test is a method used in the current medical device biological evaluation standards at home and abroad to determine whether medical devices in contact with blood will pose potential risks (GB / T 16886.4-2022 Part 4 "Selection of Tests for Interaction with Blood"; ISO 10993-4:2017). The PTT method is a general screening test for the intrinsic coagulation pathway ability of medical materials. Material samples with shortened PTT time represent that they may contain activators that activate the intrinsic coagulation pathway. The current detection method of the general Designation: F2382-18 document has the following disadvantages: 1. Platelet activation and coagulation reactions are easily generated in the process of separation and extraction of whole blood after centrifugation to prepare test plasma, resulting in false results of obviously insufficient coagulation time due to platelet consumption in the subsequent test process. Moreover, the plasma sample of this method cannot completely simulate the form of contact between blood and the test object under normal conditions, which violates the original intention of the determination. 2. Because some medical devices are large, a large amount of blood samples are often required in the process of preparing test plasma. Hemolysis is common after mixing multiple blood samples, which affects the subsequent test results. 3. Glass beads are usually used in the preparation of positive test plasma. Insufficient contact area between plasma and glass beads will result in no positive results. 4. High-density polyethylene is usually used for direct extraction in the preparation of negative test plasma. Insufficient contact between plasma and high-density polyethylene will result in unstable negative results. 5. After being put on the machine, the activated partial thromboplastin time (APTT) reagent needs to be replaced with self-prepared rabbit cephalin solution as the detection reagent. The prepared rabbit cephalin is usually directly mixed with normal saline and then filtered for half an hour before use. Commercial rabbit brain gel is a waxy solid substance that is difficult to completely blend with 0.9% normal saline. The content of the rabbit cephalin solution is difficult to stabilize after standing and filtering, making it difficult to ensure the stability of the experimental conditions for each test. Summary of the invention
[0003] The purpose of the present invention is to address the defects of the prior art and to propose a kit and application for testing the partial thromboplastin time of medical devices, so as to reduce hemolysis, ensure that the test data results are more stable, and the results of repeated items are more in line with standard requirements.
[0004] The present invention solves the technical problem through the following technical scheme: firstly, a kit for testing the partial thromboplastin time of medical devices is provided, wherein the kit contains A negative control reagent-high-density polyethylene particles; B positive control reagent-non-silanized glass particles; C test reagent 1-C1 freeze-dried rabbit cephalin and C2 ion-free ultrapure water, with a mixing concentration of 0.01g / ml-0.1g / ml; D test reagent 2-calcium chloride solution 1.25mg / ml-3.00mg / ml.
[0005] Among them, the best combination is C test reagent 1 - C1 freeze-dried rabbit phospholipids\C2 ion-free ultrapure water with a mixed concentration of 0.01g / ml; D test reagent 2 - the concentration of calcium chloride solution is 2.25mg / ml.
[0006] The present invention further provides the use of the above kit, comprising the following steps: Step 1: Collect the unprepared sample in a vacuum blood collection tube (sodium citrate 3.2% or 3.8%, i.e. 0.109 mol / L or 0.129 mol / L) and store it at 2-8° for later use; Step 2: Prepare the sample to be tested at a ratio of 0.2 g / mL on a clean bench, sterilize it with ultraviolet light, mix it with the sample to be tested that has not been prepared, and then extract it for 15 minutes. Separate the extracted sample from the sample to be tested, and centrifuge the separated sample at 3000 rpm for 10 minutes to separate the upper light yellow liquid; Step 3: Weigh the high-density polyethylene particles at a ratio of 0.2 g / mL on a clean bench, mix with the test sample without sample preparation, and then extract for 15 minutes, separate the extracted test sample from the test sample, and centrifuge the separated test sample at 3000 rpm for 10 minutes to separate the upper light yellow liquid; Step 4: weigh the non-silanized glass particles at a ratio of 0.2 g / mL on a clean bench, mix them with the test sample without sample preparation, and then extract them for 15 minutes. Separate the extracted test sample from the test sample, and centrifuge the separated test sample at 3000 rpm for 10 minutes to separate the upper light yellow liquid; Step 5: The test sample without sample preparation is directly leached for 15 minutes, and the leached test sample is separated from the sample to be tested. The separated test sample is centrifuged at 3000 rpm for 10 minutes to separate the upper light yellow liquid; Step 6: Dilute the freeze-dried rabbit cephalin with ion-free ultrapure water at 0.01 g / ml and heat in a water bath at 65°C for 10 minutes. After the rabbit cephalin is completely dissolved and fully mixed, centrifuge at 4000 rpm for 10 minutes to obtain a milky white turbid liquid without precipitation as a mixed solution. Step 7. Use a fully automatic coagulation analyzer to perform PTT determination. Place the test solution obtained by mixing freeze-dried rabbit cephalin and ion-free ultrapure water and 2.25 mg / ml calcium chloride solution in the reagent position of the instrument. The instrument flow is set to take 50 μl of the test sample and 50 μl of the mixture of freeze-dried rabbit cephalin and ion-free ultrapure water equilibrated to room temperature and mix them. After incubation at 37°C for 3 minutes, immediately add 50 μl of calcium chloride solution preheated to 37°C and record the coagulation time. Step 8. According to the requirements of GB / T 14233.2-2005, statistical analysis is performed on all the measurement results to obtain the results and make judgments.
[0007] The preparation process of step 2 in the above application only needs to ensure that the surface of the prepared sample is not uneven. If the surface of the sample is uneven, it is polished with sandpaper and then washed and dried with saline before preparation.
[0008] The extraction conditions are 37°C, water bath, away from light and wind. The coagulation time is the 50% time point of the coagulation endpoint.
[0009] The above process is a sterile operation, and the extract is used immediately after extraction without any other treatment such as filtration, centrifugation, dilution, etc., and the pH is not adjusted.
[0010] The present invention keeps the test sample in the state of whole blood for extraction, which can better restore the state of contact between the test object and the blood. All samples are prepared according to the standard minimum ratio, which can reduce the amount of test samples used, solve the problems such as difficulty in collecting test samples, and do not need to mix multiple test samples, thereby reducing the factors of hemolysis and ensuring the correctness of the data. In the present invention, the non-silanized glass tube of the positive sample is ground into small particles to ensure that the positive sample can be completely in contact with the blood and produce hemolysis to release the phospholipids in the cells, thereby ensuring the reliability of the positive result. In the present invention, the use of powdered or ground high-density polyethylene as a negative sample can better contact the test sample to ensure the validity of the negative result. Rabbit cephalin is a solid freeze-dried wax, which is difficult to dissolve in water or solvents such as saline at room temperature. In the present invention, the wax is fused with pure water using the hot melting point to solve the problem of insufficient content caused by the insolubility of rabbit cephalin. The invention does not use saline but pure water to better dissolve rabbit cephalin in water, and the use of pure water is more economical and affordable than using 0.9% saline. The beneficial effects are: optimizing the method and ensuring the stability and accuracy of the test data. DETAILED DESCRIPTION
[0011] Example 1 The reagents used in the kit for testing the partial thromboplastin time of medical devices in this embodiment are as follows: high-density polyethylene particles, non-silanized glass particles, a mixture of freeze-dried rabbit cephalin and ion-free ultrapure water, a calcium chloride solution, and a blank control substance. The sources of the above reagents are all commercially available and will not be repeated here.
[0012] This example is carried out in the following manner, and a comparison is made with the existing method: Sample preparation and extraction for PTT partial thromboplastin time test: Step 1: Collect the unprepared sample in a vacuum blood collection tube (sodium citrate 3.2% or 3.8%, i.e. 0.109 mol / L or 0.129 mol / L) and store it at 2-8° for later use; Step 2: Prepare the sample to be tested at a ratio of 0.2 g / mL on a clean bench. During the preparation process, ensure that the surface of the prepared sample is not uneven. If it is uneven, use sandpaper to slightly polish it, wash it with physiological saline, dry it, and then weigh it. After ultraviolet disinfection, mix it with the sample to be tested that has not been prepared, and then extract it for 15 minutes. Separate the extracted sample from the sample to be tested, and centrifuge the separated sample at 3000 rpm / 10 minutes to separate the upper light yellow liquid; Step 3: Weigh the high-density polyethylene particles at a ratio of 0.2 g / mL on a clean bench, mix with the test sample without sample preparation, and then extract for 15 minutes, separate the extracted test sample from the test sample, and centrifuge the separated test sample at 3000 rpm for 10 minutes to separate the upper light yellow liquid; Step 4: Weigh the non-silanized glass particles at a ratio of 0.2 g / mL on a clean bench, mix with the test sample without sample preparation, and then extract for 15 minutes, separate the extracted test sample from the test sample, and centrifuge the separated test sample at 3000 rpm for 10 minutes to separate the upper light yellow liquid; Step 5: The test sample without sample preparation is directly leached for 15 minutes, and the leached test sample is separated from the sample to be tested. The separated test sample is centrifuged at 3000 rpm for 10 minutes to separate the upper light yellow liquid; Step 6: Dilute the freeze-dried rabbit cephalin with ion-free ultrapure water according to 0.01 g / ml and heat in a water bath at 65°C for 10 minutes. After the rabbit cephalin is completely dissolved and fully mixed, centrifuge at 4000 rpm for 10 minutes to obtain a milky white turbid liquid without precipitation as a mixed solution; Step 7: Use a fully automatic coagulation analyzer to perform PTT determination. Place the test solution obtained by mixing freeze-dried rabbit cephalin and ion-free ultrapure water and 2.25 mg / ml calcium chloride solution in the reagent position of the instrument. Set the instrument flow to take 50 μl of the test sample and 50 μl of the mixture of freeze-dried rabbit cephalin and ion-free ultrapure water equilibrated to room temperature and mix them. After incubation at 37°C for 3 minutes, immediately add 50 μl of calcium chloride solution preheated to 37°C and record the coagulation time. Step 8 Data Analysis 1) According to the relevant requirements of GB / T 14233.2-2005, all the test results were statistically analyzed.
[0013] 2) Quality Check: The BC% of the positive control result must be <50%; the BC% of the negative control must be >80%. If the test does not meet this specification, repeat the test until the control is within range. The difference between the replicates for each sample must be <15%. Average the replicates for each test article sample and report one value as the clotting time. The value for each test article sample must be within ±25% of this average. If the values are greater than 25% of the average, the test needs to be repeated.
[0014] 3) Evaluation criteria: Compare the average coagulation time values. If there is no significant difference in statistical analysis between the test sample and the blank control or negative control material, it means that the test sample has no effect on the partial thromboplastin time. If the value of the test sample is lower than that of the blank control group and the negative control material group, it is necessary to consider comparing it with the control sample group. If there is no significant difference between the test sample and the control sample, it means that the test sample has no effect on the partial thromboplastin time, otherwise, it has an effect.
[0015] Table 1 Data of this example
[0016] : There was a statistically significant difference between the positive control group and the control sample group (or blank control), p<0.05 (t test); #: There is no statistically significant difference between the experimental sample group and the control sample group (or blank control), p>0.05 (t test) Table 2 Comparison data
[0017] : There was a statistically significant difference between the positive control group and the control sample group (or blank control), p<0.05 (t test); #: There is no statistically significant difference between the experimental sample group and the control sample group (or blank control), p>0.05 (t test) This embodiment improves the preparation method of rabbit cephalin test solution to optimize the PTT partial thromboplastin time test. The specific method is as follows: (1) Reagent C (lyophilized rabbit cephalin) and reagent D (ion-free ultrapure water) of the kit of the present invention: dilute them in a ratio of 1:9 and place them in a water bath for heating at 65°C / 10 minutes to completely dissolve the rabbit cephalin and mix them thoroughly. Centrifuge at 4000 rpm / 10 minutes to obtain a milky white turbid liquid without precipitation. (2) Reagent E (calcium chloride solution 2.25 mg / ml) of the kit of the present invention: mix calcium chloride powder and ultrapure water at 2.25 mg / ml, let stand for 5 minutes before use.
[0018] Comparison of test results of the two methods The test plasma prepared by the method of the present invention in Example 1 was used to perform PTT partial thromboplastin time test with the reaction reagent solution of the prior art and the present invention, and the comparison results were as follows: Table 3 Existing technology data
[0019] : There was a statistically significant difference between the positive control group and the control sample group (or blank control), p<0.05 (t test); #: There is no statistically significant difference between the experimental sample group and the control sample group (or blank control), p>0.05 (t test)
[0020] in conclusion Improved effect of embodiment 1: According to the data in Tables 1 and 2, the improved extraction method significantly reduces the risk of blood compatibility of personnel.
[0021] The improved positive operation method makes the positive result of the technology of the present invention significantly lower than the positive result of the prior art, and is more in line with the requirements of the positive result.
[0022] According to the data in Table 3, if rabbit cephalin is not completely dissolved, the liquid concentration will be insufficient or excessive, resulting in unstable test results. Comparing the data in Table 3 with that in Table 1, it can be seen that the lower the coefficient of variation, the smaller the relative dispersion of the data, and vice versa.
[0023] This embodiment can ensure that rabbit cephalin is completely dissolved, so that the test data results are more stable and the results of the duplicate items are more in line with the standard requirements.
[0024] Overall improvement effect: According to the above examples, the present invention has made many improvements in operation details and control of uncontrollable factors. These improvements make the test more reliable. Compared with the prior art methods, the present invention significantly improves the accuracy and stability of the PTT partial thromboplastin time test. It has important application value.
[0025] Example 2 In order to prove that the concentrations of the test reagent 1 and the test reagent 2 in the present invention are the optimal concentrations, a gradient exploration of the reagent concentrations was performed.
[0026] This embodiment optimizes and confirms the reagent concentration recommended by the present invention by preparing different concentrations of test reagents 1 and 2. The current optimal concentration is established when the linear range of the instrument is greater than 3 seconds and less than 360 seconds. The following specific test steps are obtained based on the literature and standard concentrations: Step 1: Prepare different doses of test reagent 1 and test reagent 2 The preparation concentrations of rabbit cephalin are 0.001g / ml, 0.005g / ml, 0.01g / ml, 0.05g / ml, and 0.1g / ml.
[0027] The preparation concentrations of calcium chloride solution are 1.25mg / ml, 1.75mg / ml, 2.25mg / ml, 2.75mg / ml, and 3.00mg / ml.
[0028] Step 2: Operation on the machine According to the operation steps and methods of the present invention, samples are collected, positive test samples and blank test samples are prepared, and when verifying test reagent 1, test reagent 2 is used at a concentration of 2.25 mg / ml and the corresponding program is set on the fully automatic coagulation analyzer for testing. The reagent concentration setting is based on the concentration of the common APTT test kit on the market.
[0029] According to the operation steps and methods of the present invention, samples are collected, positive test samples and blank test samples are prepared, and when verifying test reagent 2, the concentration of test reagent 1 is 0.01 g / ml and the corresponding program is set on the fully automatic coagulation analyzer for testing. The reagent concentration setting is based on the concentration of the common APTT test kit on the market.
[0030] Step 3: Data Analysis Table 4 Test reagent 1 concentration comparison data
[0031] Remark:" ”The data represent that it is impossible to obtain data beyond linearity;
[0032] Table 5 Test reagent 2 concentration comparison data
[0033] Remark:" ” Data represents beyond linearity and no data can be obtained.
[0034] It can be seen from Table 4 that under the experimental conditions, when the reagent concentration is lower than 0.005 g / ml, the data results are closer to the maximum value of the linear range, and when it is lower than 0.01 g / ml, the test data is likely to exceed the linear range.
[0035] It can be seen from Table 5 that under the experimental conditions, when the reagent concentration is lower than or equal to 1.25 mg / ml, the data results are closer to the maximum value of the linear range, and when it is lower than 2.25 g / ml, the data are likely to exceed the linear range.
[0036] Conclusion Through the above test data and past test data, it is found that the source of sample preparation may also cause the test data to exceed the linearity, so the selection of the appropriate concentration should be based on the linearity of the instrument. Currently, most instruments on the market have a minimum and maximum test range of more than 3 seconds and less than 360 seconds. Under the experimental conditions, the recommended concentration of the reagent of the present invention is most consistent with the linear range of most instruments on the market.
[0037] In addition to the above implementations, the present invention may also have other implementations. Any technical solution formed by equivalent replacement or equivalent transformation falls within the protection scope required by the present invention.
Claims
1. A kit for testing partial thromboplastin time of medical devices, characterized in that: The kit contains A negative control reagent-high-density polyethylene particles; B Positive control reagent-non-silanized glass particles; C Test Reagent 1-C1 freeze-dried rabbit phospholipids and C2 ion-free ultrapure water mixed concentration is 0.01g / ml-0.1g / ml; D Test Reagent 2 - Concentration of calcium chloride solution 1.25 mg / ml - 3.00 mg / ml.
2. The kit for testing the partial thromboplastin time of medical devices according to claim 1, characterized in that: The mixed concentration of the C1 freeze-dried rabbit phospholipids and C2 ion-free ultrapure water is 0.01 g / ml; the concentration of the 2-calcium chloride solution is 2.25 mg / ml.
3. The use of the kit for testing the partial thromboplastin time of medical devices according to claim 1, characterized in that: The following steps are involved: Step 1: Collect the unprepared sample using a vacuum blood collection tube and store it at 2-8° for future use; Step 2: Prepare the sample to be tested at a ratio of 0.2 g / mL on a clean bench, sterilize it with ultraviolet light, mix it with the sample to be tested that has not been prepared, and then extract it for 15 minutes. Separate the extracted sample from the sample to be tested, and centrifuge the separated sample at 3000 rpm for 10 minutes to separate the upper light yellow liquid; Step 3: In a clean bench, mix the high-density polyethylene particles at a ratio of 0.2 g / mL with the sample to be tested without sample preparation, and then extract for 15 minutes. Separate the extracted sample from the sample to be tested, and centrifuge the separated sample at 3000 rpm for 10 minutes to separate the upper light yellow liquid; Step 4: On a clean bench, the non-silanized glass particles were mixed with the sample for testing without sample preparation at a ratio of 0.2 g / mL and then leached for 15 minutes, the leached sample for testing was separated from the sample to be tested, and the separated sample for testing was centrifuged at 3000 rpm for 10 minutes to separate the upper light yellow liquid; Step 5: The test sample without sample preparation is directly leached for 15 minutes, and the leached test sample is separated from the sample to be tested. The separated test sample is centrifuged at 3000 rpm for 10 minutes to separate the upper light yellow liquid; Step 6: Dilute the freeze-dried rabbit cephalin with ion-free ultrapure water at 0.01 g / ml and heat in a water bath at 65°C for 10 minutes. After the rabbit cephalin is completely dissolved and fully mixed, centrifuge at 4000 rpm for 10 minutes to obtain a milky white turbid liquid without precipitation as a mixed solution. Step 7. Use a fully automatic coagulation analyzer to perform PTT determination. Place the test solution obtained by mixing freeze-dried rabbit cephalin and ion-free ultrapure water and 2.25 mg / ml calcium chloride solution in the reagent position of the instrument. The instrument flow is set to take 50 μl of the test sample and 50 μl of the mixture of freeze-dried rabbit cephalin and ion-free ultrapure water equilibrated to room temperature and mix them. After incubation at 37°C for 3 minutes, immediately add 50 μl of calcium chloride solution preheated to 37°C and record the coagulation time. Step 8. According to the requirements of GB / T 14233.2-2005, statistical analysis is performed on all the measurement results to obtain the results and make judgments.
4. The use of the kit for testing the partial thromboplastin time of medical devices according to claim 3, characterized in that: The preparation process of step 2 ensures that the surface of the prepared sample is not uneven. When the surface of the sample is uneven, it is polished with sandpaper and then washed with saline and dried before preparation.
5. The use of the kit for testing the partial thromboplastin time of medical devices according to claim 3, characterized in that: The extraction conditions are 37° C. in a water bath, away from light and wind.
6. The use of the kit for testing the partial thromboplastin time of medical devices according to claim 3, characterized in that: The coagulation time was the 50% time point of the coagulation endpoint.
Citation Information
Patent Citations
External diagnostic reagent kit used for measuring activated partial thromboplastin time
CN101221189A
In-vitro diagnostic kit for determining activated partial thromboplastin time
CN111638375A
Preparation method of blood perfusion adsorbent with good blood compatibility
CN118807707A
